| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 10/24/2002 | US20020154535 High density non-volatile memory device |
| 10/24/2002 | CA2443490A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 10/23/2002 | EP1251134A1 Novel carbapenem derivatives of quaternary salt type |
| 10/23/2002 | EP1251133A1 Novel carbapenem derivatives |
| 10/23/2002 | EP1250334A2 Agents and methods for the treatment of proliferative diseases |
| 10/23/2002 | CN1376156A Benzodiazepin derivatives, the production and use thereof |
| 10/17/2002 | WO2002081480A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
| 10/17/2002 | WO2002081475A1 Jun kinase inhibitors |
| 10/17/2002 | WO2002081471A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 10/17/2002 | WO2002080926A1 Pyrazolopyrimidines as therapeutic agents |
| 10/17/2002 | CA2442141A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
| 10/17/2002 | CA2440724A1 Pyrazolopyrimidines as therapeutic agents |
| 10/16/2002 | EP1249451A2 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 10/16/2002 | EP1248784A1 Condensed azepines as vasopressin agonists |
| 10/16/2002 | EP1248617A1 2-aza-bicyclo 2.2.2]octane nmda/nr2b antagonists |
| 10/16/2002 | EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 10/15/2002 | US6465648 Obtainable by reacting (i) a nitrile derivative, (ii) a phthalonitrile derivative or a 1,3-diiminoisoindoline derivative and, if necessary, (iii) a metal or a metal-containing compound, such as titanium. |
| 10/15/2002 | US6465507 Antitumor agents |
| 10/15/2002 | US6464902 Perylene mixtures |
| 10/10/2002 | WO2002079206A1 Method for reducing leurosine in anhydrovinblastine |
| 10/08/2002 | US6462196 Preparation of a camptothecin derivative by intramolecular cyclization |
| 10/08/2002 | US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis |
| 10/08/2002 | US6462041 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 10/08/2002 | US6461747 Materials for light emitting devices good in light emitting characteristics, excellent in stability in repeated use thereof, and excellent in color purity |
| 10/08/2002 | US6461567 Device and method for photoactivation |
| 10/08/2002 | US6461538 Production process for indolizine compounds and their use in organic light-emitting devices |
| 10/06/2002 | WO2003088897A2 Fab i inhibitors |
| 10/06/2002 | CA2444597A1 Fab i inhibitors |
| 10/03/2002 | WO2002076986A1 Pyrazolopyrimidines as therapeutic agents |
| 10/03/2002 | WO2002076404A2 Fatty alcohol drug conjugates |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | WO2002076399A2 YOHIMBINE DIMERS EXHIBITING BINDING SELECTIVITES FOR α2 ADRENERGIC RECEPTORS |
| 10/03/2002 | WO2002076397A2 Telomerase inhibitors and methods of their use |
| 10/03/2002 | WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles |
| 10/03/2002 | WO2001085095A3 Chiral fluoroquinolizinone arginine salt forms |
| 10/02/2002 | EP1244450A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists |
| 10/02/2002 | CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 10/02/2002 | CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them |
| 10/01/2002 | US6458802 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline |
| 10/01/2002 | US6458792 Medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or cns-degenerative disorders. |
| 10/01/2002 | US6458780 Carbapenem derivatives |
| 09/26/2002 | WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof |
| 09/26/2002 | WO2002024692A8 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 09/26/2002 | US20020137925 Regioisomerically pure oxochlorins and methods of synthesis |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242423A1 SUBSTITUTED 1,2,3-TRIAZOLO 1,5-a]QUINAZOLINES FOR ENHANCING COGNITION |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/19/2002 | WO2002072587A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline |
| 09/19/2002 | WO2002072581A2 Pyrazolopyriadine derivatives |
| 09/18/2002 | CN1370176A Subsstituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370169A Substituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370168A Novel spiro compounds |
| 09/18/2002 | CN1369494A Compound with intramolecule change transfer and its preparing process |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | CA2440803A1 Modulators of chemokine receptor activity |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237890A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 09/06/2002 | WO2002068419A1 Pyridopyrimidine or naphthyridine derivative |
| 09/06/2002 | WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | WO2002055520A3 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/04/2002 | EP1235938A2 Fluorescent quenching detection reagents and methods |
| 09/04/2002 | EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/04/2002 | EP1235829A2 Pyrazolo 1,5-d] 1,2,4]triazines for enhancing cognition |
| 09/04/2002 | EP1235826A1 Quinuclidine acrylamides |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235574A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/04/2002 | EP1036076B1 Novel compounds |
| 09/04/2002 | EP1022279B1 New carbapenem derivatives |
| 09/04/2002 | CN1367173A Metal phthalocyanine compound, its preparation method and application |
| 08/29/2002 | WO2002066484A1 Isoxazoline derivatives as anti-depressants |
| 08/29/2002 | WO2002048109A3 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 08/29/2002 | WO2002030930A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002018383A3 Aza heterocyclic derivatives and their therapeutic use |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/28/2002 | EP1021438A4 Trioxane dimer compounds having antiproliferative and antitumor activities |
| 08/28/2002 | CN1365978A Process for extracting active anticancer component from vinca flower |
| 08/27/2002 | US6441174 Process for preparing bis(hydroxymethyl)perylenetetracarboximide |
| 08/27/2002 | US6440971 Binuclear complex |
| 08/22/2002 | WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064594A2 6-substituted pyrido-pyrimidines |
| 08/22/2002 | WO2002064590A2 Carboline derivatives |
| 08/22/2002 | WO2002020533A3 Benzoxazine alpha-1 adrenergic compounds |
| 08/22/2002 | US20020115896 Asymmetric hydride reductions of carbonyl groups using a chiral non-racemic phase transfer catalyst, a helper nucleophile, and a sterically bulky reagent nucleophile |
| 08/22/2002 | US20020115684 2, 7-naphthyridine derivatives |
| 08/22/2002 | US20020115566 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 08/22/2002 | US20020114836 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 08/22/2002 | CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/21/2002 | EP0971924B1 Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
| 08/21/2002 | CN1089341C Pyridonecarboxylic acid derivatives and intermediates for synthesis and use thereof |
| 08/20/2002 | US6437119 Forming acid chloride of nalidixic acid, perfloxacin, or ofloxacin with thionyl chloride, condensing with betalactam, intermediate reacts with triaryl phosphine and carbon tetrachloride, then tetracycline, metronidazole, chloramphen |
| 08/15/2002 | WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 08/15/2002 | US20020111375 Antitumor agents |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1230246A2 Novel thiophenes and method for polymerization of said thiophenes |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |